U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. For Industry
  3. FDA User Fee Programs
  4. Prescription Drug User Fee Amendments
  5. Exhibit 4-19 long description
  1. Prescription Drug User Fee Amendments

Exhibit 4-19 long description

The distribution within the 17 review divisions of the Fast-Track versus Pilot 1 products is as follows. The following divisions had Pilot 1 products: Cardiovascular and renal had 1 product, Gastroenterology had 1 product, Anti-infectives and Ophthalmology had 6 products, Drug Oncology had 14 products, Medical Imaging and Hematology had 1 product, Biological Oncology had 2 products and Therapeutic Biologics had 2 products. The divisions that had Fast-Track products that were not Pilot 1 are 2 products in Neurology, 1 product in Pulmonary and Allergy, and 6 products in Anti-Virals.

Back to Top